Ilka Hoof
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Ilka Hoof has a total of 222 co-authors. Here are the top co-authors by number of shared publications:
Can Keşmir
Theoretical Biology and Bioinformatics, Utrecht University , Utrecht , Netherlands
7 shared publications- Morten Nielsen
Department of Health Technology, Technical University of Denmark, DK-2800 Lyngby, Denmark
6 shared publications - Ole Lund
Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark
6 shared publications Debbie van Baarle
Centre for Infectious Disease Control, National Institute for Public Health and the Environment , Bilthoven , Netherlands ; Laboratory of Translational Immunology, Department of Immunology, University Medical Center Utrecht , Utrecht , Netherlands ; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht , Utrecht , Netherlands
5 shared publicationsAlessandro Sette
Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, USA
4 shared publicationsJohn Sidney
Department of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, USA
4 shared publications
Latest Publications
- Open Access
An Integrated Genomic and Transcriptomic Analysis Reveals Distinct Molecular Features Associated with Mild-to-moderate Atopic Dermatitis
Atopic dermatitis (AD) is a common skin disorder, characterized by impaired skin barrier function and cutaneous inflammation. The pathophysiology of AD is incompletely understood, and has considerable genetic contributions. To obtain a detailed molecular understanding of AD, we integrated the genomic, skin transcriptomic, and clinical measurements from 30 AD and 30 healthy control (HC) subjects. We found that the AD group had mild-to-moderate disease severity and only showed slightly increased genetic risk compared with HC. When comparing within the AD group, we found that the lesional skin of patients with increased genetic risk was characterized by a possible “self-protection” mechanism, including elevation of the anti-inflammatory cytokine IL-34, activation of fibroblasts, wound healing, and the complement system. We hypothesize that this mechanism may contribute to halting further progression of AD.
Open AccessAn Integrated Genomic and Transcriptomic Analysis Reveals Distinct Molecular Features Associated with Mild-to-moderate Atopic Dermatitis
Atopic dermatitis (AD) is a common skin disorder, characterized by impaired skin barrier function and cutaneous inflammation. The pathophysiology of AD is incompletely understood, and has considerable genetic contributions. To obtain a detailed molecular understanding of AD, we integrated the genomic, skin transcriptomic, and clinical measurements from 30 AD and 30 healthy control (HC) subjects. We found that the AD group had mild-to-moderate disease severity and only showed slightly increased genetic risk compared with HC. When comparing within the AD group, we found that the lesional skin of patients with increased genetic risk was characterized by a possible “self-protection” mechanism, including elevation of the anti-inflammatory cytokine IL-34, activation of fibroblasts, wound healing, and the complement system. We hypothesize that this mechanism may contribute to halting further progression of AD.
- Open Access
A Distinct Phenotype of Polarized Memory B cell holds IgE Memory
Allergen-specific IgE antibodies mediate allergic pathology in diseases such as allergic rhinitis and food allergy. Memory B cells (MBCs) contribute to circulating IgE by regenerating IgE-producing plasma cells upon allergen encounter. We report a population of type 2 polarized MBCs defined as CD23 hi , IL-4Rα hi , CD32 low at the transcriptional and surface protein levels. These “MBC2s” are enriched in IgG1 and IgG4-expressing cells, while constitutively expressing germline transcripts for IgE. Allergen-specific B cells from patients with allergic rhinitis and food allergy were enriched in MBC2s. MBC2s generated allergen specific-IgE during sublingual immunotherapy, thereby identifying these cells as the primary reservoir of IgE. The identification of MBC2s provides insights into the maintenance of IgE memory, which is detrimental in allergic diseases, but which could be beneficial in protection against venoms and helminths. One-Sentence Summary: Identification of a novel memory B cell subset which holds allergen specific IgE memory.
Open AccessA Distinct Phenotype of Polarized Memory B cell holds IgE Memory
Allergen-specific IgE antibodies mediate allergic pathology in diseases such as allergic rhinitis and food allergy. Memory B cells (MBCs) contribute to circulating IgE by regenerating IgE-producing plasma cells upon allergen encounter. We report a population of type 2 polarized MBCs defined as CD23 hi , IL-4Rα hi , CD32 low at the transcriptional and surface protein levels. These “MBC2s” are enriched in IgG1 and IgG4-expressing cells, while constitutively expressing germline transcripts for IgE. Allergen-specific B cells from patients with allergic rhinitis and food allergy were enriched in MBC2s. MBC2s generated allergen specific-IgE during sublingual immunotherapy, thereby identifying these cells as the primary reservoir of IgE. The identification of MBC2s provides insights into the maintenance of IgE memory, which is detrimental in allergic diseases, but which could be beneficial in protection against venoms and helminths. One-Sentence Summary: Identification of a novel memory B cell subset which holds allergen specific IgE memory.
- Open Access
- 8 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , 612-620.e6
Assessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Minipunch Biopsies
- 8 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (4) , 612-620.e6
Open AccessAssessment of Spatial and Temporal Variation in the Skin Transcriptome of Atopic Dermatitis by Use of 1.5 mm Minipunch Biopsies
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , OA1483
Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Allergy to house dust mites (HDM) is a common cause of allergic asthma and can be effectively treated with allergy immunotherapy (AIT). Specific single-nucleotide polymorphisms (SNPs) have been associated with asthma, and specifically for the 17q12-21 locus, this association has been shown to be modifiable by environmental factors. The aim of this study was to test whether asthma-associated SNPs have an impact on the response to AIT. MITRA (Clinicaltrialsregister.eu 2010-018621-19) was a phase III, randomized, double-blind, placebo-controlled trial of HDM sublingual immunotherapy (SLIT)-tablets in adults with HDM allergic asthma. A post-hoc analysis of the MITRA study population evaluated associations between 22 asthma-risk SNPs and the primary study endpoint (time to first moderate/severe asthma exacerbation) in 582 genotyped patients. SNP rs7216389, located in the chromosomal region 17q12-21, showed a significant interaction with treatment (P=0.037): While the overall patient population had a relative risk reduction in moderate-severe asthma exacerbations (N=582, HR=0.65, 95% CI [0.48, 0.89]; P=0.008), patients homozygous for the risk allele had an even greater risk reduction (N=173, HR=0.37 [0.22, 0.64], P<0.001). The association of rs7216389 with exacerbation risk in HDM-sensitized asthmatics was verified in an independent SARP3 patient cohort (N=160, β=0.38 [0.04, 0.73], P=0.03). Our results indicate that HDM SLIT-tablet AIT is efficacious in HDM-sensitized asthma patients with a genetic predisposition to asthma. Therefore, our findings have the potential to form the basis for prospective asthma prevention strategies.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , OA1483
Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Allergy to house dust mites (HDM) is a common cause of allergic asthma and can be effectively treated with allergy immunotherapy (AIT). Specific single-nucleotide polymorphisms (SNPs) have been associated with asthma, and specifically for the 17q12-21 locus, this association has been shown to be modifiable by environmental factors. The aim of this study was to test whether asthma-associated SNPs have an impact on the response to AIT. MITRA (Clinicaltrialsregister.eu 2010-018621-19) was a phase III, randomized, double-blind, placebo-controlled trial of HDM sublingual immunotherapy (SLIT)-tablets in adults with HDM allergic asthma. A post-hoc analysis of the MITRA study population evaluated associations between 22 asthma-risk SNPs and the primary study endpoint (time to first moderate/severe asthma exacerbation) in 582 genotyped patients. SNP rs7216389, located in the chromosomal region 17q12-21, showed a significant interaction with treatment (P=0.037): While the overall patient population had a relative risk reduction in moderate-severe asthma exacerbations (N=582, HR=0.65, 95% CI [0.48, 0.89]; P=0.008), patients homozygous for the risk allele had an even greater risk reduction (N=173, HR=0.37 [0.22, 0.64], P<0.001). The association of rs7216389 with exacerbation risk in HDM-sensitized asthmatics was verified in an independent SARP3 patient cohort (N=160, β=0.38 [0.04, 0.73], P=0.03). Our results indicate that HDM SLIT-tablet AIT is efficacious in HDM-sensitized asthma patients with a genetic predisposition to asthma. Therefore, our findings have the potential to form the basis for prospective asthma prevention strategies.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA877
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Many individuals with asthma have an underlying allergy, and house dust mites (HDMs) are a common trigger. Biomarkers of the type 2 (Th2) immune response are associated with severity of allergic asthma. The aim of this study was to investigate the association between baseline values of Th2 biomarkers and efficacy of sublingual allergy immunotherapy (SLIT)-tablet treatment. MITRA (Clinicaltrialsregister.eu 2010-018621-19) was a phase III, randomized, double-blind, placebo-controlled trial of HDM SLIT-tablets in 834 adults with HDM allergic asthma. A post-hoc analysis of the MITRA study population was performed to evaluate the association between baseline levels of the Th2 inflammatory biomarkers blood eosinophils, eosinophil cationic protein (ECP), total IgE and tryptase and the primary study endpoint (time to first moderate/severe asthma exacerbation). High levels of Th2/allergic biomarkers were associated with increased risk of asthma exacerbations in the placebo group (blood eosinophils: HR=1.7, 95% CI [1.07, 2.71]; ECP: HR=1.76 [1.1, 2.82]; tryptase: HR=1.76 [1.08, 2.86]), but HDM SLIT-tablet treatment reduced this elevated risk in the Th2 biomarker ‘high’ subgroup (blood eosinophils: HR=0.5 [0.30, 0.85]; ECP: HR=0.5 [0.29, 0.87]; tryptase: HR=0.45 [0.25, 0.80]), where ‘high’ was defined as values above the 80th percentile per individual biomarker. Our results indicate that AIT with HDM SLIT-tablets is effective in HDM-sensitized asthma patients with high levels of Th2 inflammatory biomarkers.
- 5 September 2021
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (suppl 65) , PA877
Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma
Many individuals with asthma have an underlying allergy, and house dust mites (HDMs) are a common trigger. Biomarkers of the type 2 (Th2) immune response are associated with severity of allergic asthma. The aim of this study was to investigate the association between baseline values of Th2 biomarkers and efficacy of sublingual allergy immunotherapy (SLIT)-tablet treatment. MITRA (Clinicaltrialsregister.eu 2010-018621-19) was a phase III, randomized, double-blind, placebo-controlled trial of HDM SLIT-tablets in 834 adults with HDM allergic asthma. A post-hoc analysis of the MITRA study population was performed to evaluate the association between baseline levels of the Th2 inflammatory biomarkers blood eosinophils, eosinophil cationic protein (ECP), total IgE and tryptase and the primary study endpoint (time to first moderate/severe asthma exacerbation). High levels of Th2/allergic biomarkers were associated with increased risk of asthma exacerbations in the placebo group (blood eosinophils: HR=1.7, 95% CI [1.07, 2.71]; ECP: HR=1.76 [1.1, 2.82]; tryptase: HR=1.76 [1.08, 2.86]), but HDM SLIT-tablet treatment reduced this elevated risk in the Th2 biomarker ‘high’ subgroup (blood eosinophils: HR=0.5 [0.30, 0.85]; ECP: HR=0.5 [0.29, 0.87]; tryptase: HR=0.45 [0.25, 0.80]), where ‘high’ was defined as values above the 80th percentile per individual biomarker. Our results indicate that AIT with HDM SLIT-tablets is effective in HDM-sensitized asthma patients with high levels of Th2 inflammatory biomarkers.
Diverse and highly cross-reactive T-cell responses in ragweed allergic patients independent of geographical region
Background Ragweed frequently causes seasonal allergies in North America and Europe. In the United States, several related ragweed species with diverse geographical distribution cause allergic symptoms. Cross-reactivity towards related ragweed species of IgE and treatment-induced IgG(4) has been demonstrated previously. However, less is known about the underlying T-cell cross-reactivity. Methods The allergen content of ragweed extracts was determined by mass spectrometry and related to T-cell epitopes of Amb a allergens (group 1, 3, 4, 5, 8 and 11) in 20 American ragweed allergic patients determined by FluoroSpot and proliferation assays. T-cell responses to 50 frequently recognized Amb a-derived T-cell epitopes and homologous peptides from western ragweed (Amb p), giant ragweed (Amb t) and mugwort (Art v) were investigated in an additional 11 American and 14 Slovakian ragweed allergic donors. Results Ragweed extracts contained all known allergens and isoallergens thereof. Donor T-cell responses were diverse and directed against all Amb a 1 isoallergens and to most minor allergens investigated. Similar response patterns were seen in American and Slovakia donors. Several epitopes were cross-reactive between isoallergens and ragweed species, some even including mugwort. T-cell cross-reactivity generally correlated with allergen sequence homology. Conclusion T-cell epitopes of multiple allergens/isoallergens are involved in the diverse T-cell responses in ragweed allergic individuals. T-cell lines were highly cross-reactive to epitopes of related ragweed species without any apparent geographical response bias. These data support that different ragweed species can be considered an allergen homology group with Amb a as the representative species regarding diagnosis as well as allergy immunotherapy.
Diverse and highly cross-reactive T-cell responses in ragweed allergic patients independent of geographical region
Background Ragweed frequently causes seasonal allergies in North America and Europe. In the United States, several related ragweed species with diverse geographical distribution cause allergic symptoms. Cross-reactivity towards related ragweed species of IgE and treatment-induced IgG(4) has been demonstrated previously. However, less is known about the underlying T-cell cross-reactivity. Methods The allergen content of ragweed extracts was determined by mass spectrometry and related to T-cell epitopes of Amb a allergens (group 1, 3, 4, 5, 8 and 11) in 20 American ragweed allergic patients determined by FluoroSpot and proliferation assays. T-cell responses to 50 frequently recognized Amb a-derived T-cell epitopes and homologous peptides from western ragweed (Amb p), giant ragweed (Amb t) and mugwort (Art v) were investigated in an additional 11 American and 14 Slovakian ragweed allergic donors. Results Ragweed extracts contained all known allergens and isoallergens thereof. Donor T-cell responses were diverse and directed against all Amb a 1 isoallergens and to most minor allergens investigated. Similar response patterns were seen in American and Slovakia donors. Several epitopes were cross-reactive between isoallergens and ragweed species, some even including mugwort. T-cell cross-reactivity generally correlated with allergen sequence homology. Conclusion T-cell epitopes of multiple allergens/isoallergens are involved in the diverse T-cell responses in ragweed allergic individuals. T-cell lines were highly cross-reactive to epitopes of related ragweed species without any apparent geographical response bias. These data support that different ragweed species can be considered an allergen homology group with Amb a as the representative species regarding diagnosis as well as allergy immunotherapy.
- Open Access
Purification and molecular characterization of phospholipase, antigen 5 and hyaluronidases from the venom of the Asian hornet ( Vespa velutina )
The aim of this study was to purify potential allergenic components of Vespa velutina venom, the yellow legged Asian Hornet, and perform a preliminary characterization of the purified proteins. Starting from the whole venom of V.velutina , several chromatographic steps allowed to purify the phospholipase (named Vesp v 1), as well as the antigen 5 (Vesp v 5, the only allergenic component described as such so far). The two hyaluronidase isoforms found (Vesp v 2A and Vesp v 2B) cannot be separated from each other, but they are partially purified and characterized. Purity of the isolated proteins in shown by SDSPAGE, as well as by the results of the N-terminal sequencing. This characterization and nLC-MS/MS data provide most of the sequence for Vesp v 1 and Vesp v 5 (72 and 84% coverage, respectively), confirming that the whole sequences of the isolated natural components match with the data available in public transcriptomic databases. It is of particular interest that Vesp v 1 is a glycosylated phospholipase, a fact that had only described so far for the corresponding allergen components of Dolichovespula maculata and Solenopsis invicta . The availability of the complete sequences of Vespa velutina components permits comparison with homologous sequences from other Hymenoptera. These data demonstrate the higher similarity among the species of the genera Vespa and Vespula , in comparison to Polistes species, as it is especially observed with the hyaluronidases isoforms: the isoform Vesp v 2A only exists in the former genera, and not in Polistes ; in addition, the most abundant isoform (Vesp v 2B) exhibits 93% sequence identity with the Ves v 2 isoform of Vespula vulgaris. Finally, the isolated components might be useful for improving the diagnosis of patients that could be allergic to stings of this invasive Asian hornet, as it has been the case of an improved diagnosis and treatment of other Hymenoptera-sensitized patients. Data Availability Statement: Proteomic study data are deposited and made available publicly when data are published with the ProteomeExchange identifier PXD015381 in the Mass spectrometry Interactive Virtual Environment (MassIVE). Allergen nomenclature for Vesp v 5 (and also for any future demonstrated allergen from Vespa velutina ) has been approved by the WHO/IUIS Committee ( www.allergen.org ); when this manuscript is accepted, the WHO/IUIS Committee will be informed so that the complete sequences included in this manuscript are also included in their database (with links to the UNIPROT database, who will also be informed that the data can be made public).
Open AccessPurification and molecular characterization of phospholipase, antigen 5 and hyaluronidases from the venom of the Asian hornet ( Vespa velutina )
The aim of this study was to purify potential allergenic components of Vespa velutina venom, the yellow legged Asian Hornet, and perform a preliminary characterization of the purified proteins. Starting from the whole venom of V.velutina , several chromatographic steps allowed to purify the phospholipase (named Vesp v 1), as well as the antigen 5 (Vesp v 5, the only allergenic component described as such so far). The two hyaluronidase isoforms found (Vesp v 2A and Vesp v 2B) cannot be separated from each other, but they are partially purified and characterized. Purity of the isolated proteins in shown by SDSPAGE, as well as by the results of the N-terminal sequencing. This characterization and nLC-MS/MS data provide most of the sequence for Vesp v 1 and Vesp v 5 (72 and 84% coverage, respectively), confirming that the whole sequences of the isolated natural components match with the data available in public transcriptomic databases. It is of particular interest that Vesp v 1 is a glycosylated phospholipase, a fact that had only described so far for the corresponding allergen components of Dolichovespula maculata and Solenopsis invicta . The availability of the complete sequences of Vespa velutina components permits comparison with homologous sequences from other Hymenoptera. These data demonstrate the higher similarity among the species of the genera Vespa and Vespula , in comparison to Polistes species, as it is especially observed with the hyaluronidases isoforms: the isoform Vesp v 2A only exists in the former genera, and not in Polistes ; in addition, the most abundant isoform (Vesp v 2B) exhibits 93% sequence identity with the Ves v 2 isoform of Vespula vulgaris. Finally, the isolated components might be useful for improving the diagnosis of patients that could be allergic to stings of this invasive Asian hornet, as it has been the case of an improved diagnosis and treatment of other Hymenoptera-sensitized patients. Data Availability Statement: Proteomic study data are deposited and made available publicly when data are published with the ProteomeExchange identifier PXD015381 in the Mass spectrometry Interactive Virtual Environment (MassIVE). Allergen nomenclature for Vesp v 5 (and also for any future demonstrated allergen from Vespa velutina ) has been approved by the WHO/IUIS Committee ( www.allergen.org ); when this manuscript is accepted, the WHO/IUIS Committee will be informed so that the complete sequences included in this manuscript are also included in their database (with links to the UNIPROT database, who will also be informed that the data can be made public).
- 29 September 2016
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 47 (4) , 577-592
Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity
Summary: Background: House dust mite (HDM) allergens are a common cause of allergy and allergic asthma. A comprehensive analysis of proteins targeted by T cells, which are implicated in the development and regulation of allergic disease independent of their antibody reactivity, is still lacking.Objective: To comprehensively analyse the HDM‐derived protein targets of T cell responses in HDM‐allergic individuals, and investigate their correlation with IgE/IgG responses and protein function.Methods: Proteomic analysis (liquid chromatography–tandem mass spectrometry) of HDM extracts identified 90 distinct protein clusters, corresponding to 29 known allergens and 61 novel proteins. Peripheral blood mononuclear cells (PBMC) from 20 HDM‐allergic individuals were stimulated with HDM extracts and assayed with a set of ~2500 peptides derived from these 90 protein clusters and predicted to bind the most common HLA class II types. 2D immunoblots were made in parallel to elucidate IgE and IgG reactivity, and putative function analyses were performed in silico according to Gene Ontology annotations.Results: Analysis of T cell reactivity revealed a large number of T cell epitopes. Overall response magnitude and frequency was comparable for known and novel proteins, with 15 antigens (nine of which were novel) dominating the total T cell response. Most of the known allergens that were dominant at the T cell level were also IgE reactive, as expected, while few novel dominant T cell antigens were IgE reactive. Among known allergens, hydrolase activity and detectable IgE/IgG reactivity are strongly correlated, while no protein function correlates with immunogenicity of novel proteins. A total of 106 epitopes accounted for half of the total T cell response, underlining the heterogeneity of T cell responses to HDM allergens.Conclusions and Clinical Relevance: Herein, we define the T cell targets for both known allergens and novel proteins, which may inform future diagnostics and immunotherapeutics for allergy to HDM.
- 29 September 2016
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 47 (4) , 577-592
Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity
Summary: Background: House dust mite (HDM) allergens are a common cause of allergy and allergic asthma. A comprehensive analysis of proteins targeted by T cells, which are implicated in the development and regulation of allergic disease independent of their antibody reactivity, is still lacking.Objective: To comprehensively analyse the HDM‐derived protein targets of T cell responses in HDM‐allergic individuals, and investigate their correlation with IgE/IgG responses and protein function.Methods: Proteomic analysis (liquid chromatography–tandem mass spectrometry) of HDM extracts identified 90 distinct protein clusters, corresponding to 29 known allergens and 61 novel proteins. Peripheral blood mononuclear cells (PBMC) from 20 HDM‐allergic individuals were stimulated with HDM extracts and assayed with a set of ~2500 peptides derived from these 90 protein clusters and predicted to bind the most common HLA class II types. 2D immunoblots were made in parallel to elucidate IgE and IgG reactivity, and putative function analyses were performed in silico according to Gene Ontology annotations.Results: Analysis of T cell reactivity revealed a large number of T cell epitopes. Overall response magnitude and frequency was comparable for known and novel proteins, with 15 antigens (nine of which were novel) dominating the total T cell response. Most of the known allergens that were dominant at the T cell level were also IgE reactive, as expected, while few novel dominant T cell antigens were IgE reactive. Among known allergens, hydrolase activity and detectable IgE/IgG reactivity are strongly correlated, while no protein function correlates with immunogenicity of novel proteins. A total of 106 epitopes accounted for half of the total T cell response, underlining the heterogeneity of T cell responses to HDM allergens.Conclusions and Clinical Relevance: Herein, we define the T cell targets for both known allergens and novel proteins, which may inform future diagnostics and immunotherapeutics for allergy to HDM.
- Open Access
- 2 November 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 546
Measles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation
Immunity to infections with Measles Virus (MV) can involve vigorous HLA class I restricted CD8+ cytotoxic T cell (CTL) responses. MV, albeit regarded monotypic, is known to undergo molecular evolution across its RNA genome. To address which regions of the MV proteome are eligible for recognition by CD8+ cytotoxic T cells (CTL) and how different HLA class I loci contribute to the epitope display, we interrogated the naturally processed and presented MV peptidome extracted from cell lines expressing in total a broad panel of 16 different common HLA-A, -B and -C molecules. The repertoire and abundance of MV peptides were bona fide identified by nanoHPLC-MS-MS. Eighty-nine MV peptides were discovered and assignment to an HLA-A, -B or –C allele, based on HLA-peptide affinity prediction, was in most cases successful. Length variation and presentation by multiple HLA class I molecules was common in the MV peptidome. More than twice as many unique MV epitopes were found to be restricted by HLA-B than by HLA-A, while MV peptides with supra-abundant expression rates (>5,000 copies per cell) were rather associated with HLA-A and HLA-C. In total, fifty-nine regions across the whole MV proteome were identified as targeted by HLA class I. Sequence coverage by epitopes was highest for internal proteins transcribed from the MV-P/V/C and -M genes and for haemagglutinin. At the genome level, the majority of the HLA class I selected MV epitopes represented codons having a higher non-synonymous mutation rate than silent mutation rate, as established by comparison of a set of fifty-eight unique full length MV genomes. Interestingly more molecular variation was seen for the epitopes expressed at rates ≥1,000 copies per cell. These data for the first time indicate that HLA class I broadly samples the MV proteome and that CTL pressure may contribute to the genomic evolution of MV.
- 2 November 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 546
Open AccessMeasles Virus Epitope Presentation by HLA: Novel Insights into Epitope Selection, Dominance, and Microvariation
Immunity to infections with Measles Virus (MV) can involve vigorous HLA class I restricted CD8+ cytotoxic T cell (CTL) responses. MV, albeit regarded monotypic, is known to undergo molecular evolution across its RNA genome. To address which regions of the MV proteome are eligible for recognition by CD8+ cytotoxic T cells (CTL) and how different HLA class I loci contribute to the epitope display, we interrogated the naturally processed and presented MV peptidome extracted from cell lines expressing in total a broad panel of 16 different common HLA-A, -B and -C molecules. The repertoire and abundance of MV peptides were bona fide identified by nanoHPLC-MS-MS. Eighty-nine MV peptides were discovered and assignment to an HLA-A, -B or –C allele, based on HLA-peptide affinity prediction, was in most cases successful. Length variation and presentation by multiple HLA class I molecules was common in the MV peptidome. More than twice as many unique MV epitopes were found to be restricted by HLA-B than by HLA-A, while MV peptides with supra-abundant expression rates (>5,000 copies per cell) were rather associated with HLA-A and HLA-C. In total, fifty-nine regions across the whole MV proteome were identified as targeted by HLA class I. Sequence coverage by epitopes was highest for internal proteins transcribed from the MV-P/V/C and -M genes and for haemagglutinin. At the genome level, the majority of the HLA class I selected MV epitopes represented codons having a higher non-synonymous mutation rate than silent mutation rate, as established by comparison of a set of fifty-eight unique full length MV genomes. Interestingly more molecular variation was seen for the epitopes expressed at rates ≥1,000 copies per cell. These data for the first time indicate that HLA class I broadly samples the MV proteome and that CTL pressure may contribute to the genomic evolution of MV.
- Open Access
- 29 October 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 552
HLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance
Hepatitis C virus (HCV) infections affect more than 170 million people worldwide. Most of these individuals are chronically infected, but some clear the infection rapidly. Host factors seem to play a key role in HCV clearance, among them the human leukocyte antigen (HLA) class I molecules. Certain HLA molecules, e.g. B*27 and B*57, are associated with viral clearance. To identify potential mechanisms for these associations, we assess epitope distribution differences between HLA molecules using experimentally verified and in silico predicted HCV epitopes. Specifically, we show that the NS5B protein harbors the largest fraction of conserved regions among all HCV proteins, which could be good targets for cytotoxic T cell (CTL) responses. We find that the protective HLA-B*27 molecule preferentially presents cytotoxic T cell (CTL) epitopes from NS5B, and in general presents the most strongly conserved epitopes among the 23 HLA molecules analyzed. In contrast, HLA molecules known to be associated with HCV persistence do not have similar preferences, and appear to target the variable P7 protein. Overall, our analysis suggests that by targeting highly constrained - and thereby conserved - regions of HCV, the protective HLA molecule HLA-B*27 reduces the ability of HCV to escape the cytotoxic T cell response of the host. For visualizing the distribution of both experimentally verified and predicted epitopes across the HCV genome, we created the HCV epitope browser, which is available at theory.bio.uu.nl/ucqi/hcv.
- 29 October 2015
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 6, 552
Open AccessHLA Preferences for Conserved Epitopes: A Potential Mechanism for Hepatitis C Clearance
Hepatitis C virus (HCV) infections affect more than 170 million people worldwide. Most of these individuals are chronically infected, but some clear the infection rapidly. Host factors seem to play a key role in HCV clearance, among them the human leukocyte antigen (HLA) class I molecules. Certain HLA molecules, e.g. B*27 and B*57, are associated with viral clearance. To identify potential mechanisms for these associations, we assess epitope distribution differences between HLA molecules using experimentally verified and in silico predicted HCV epitopes. Specifically, we show that the NS5B protein harbors the largest fraction of conserved regions among all HCV proteins, which could be good targets for cytotoxic T cell (CTL) responses. We find that the protective HLA-B*27 molecule preferentially presents cytotoxic T cell (CTL) epitopes from NS5B, and in general presents the most strongly conserved epitopes among the 23 HLA molecules analyzed. In contrast, HLA molecules known to be associated with HCV persistence do not have similar preferences, and appear to target the variable P7 protein. Overall, our analysis suggests that by targeting highly constrained - and thereby conserved - regions of HCV, the protective HLA molecule HLA-B*27 reduces the ability of HCV to escape the cytotoxic T cell response of the host. For visualizing the distribution of both experimentally verified and predicted epitopes across the HCV genome, we created the HCV epitope browser, which is available at theory.bio.uu.nl/ucqi/hcv.